Neuromyelitis optica (NMOSD) trials in Germany

2 of 4 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• No phaseTaking people
  Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies

  Where

  Dresden, Essen, München

  Age

  18 years and over

  People

  200 worldwide

  Run by

  Alexion Pharmaceuticals, Inc.

  See details and how to joinNCT05966467
• No phaseTaking people
  Study of Ultomiris® (Ravulizumab) Safety in Pregnancy

  Where

  Essen

  People

  75 worldwide

  Run by

  Alexion Pharmaceuticals, Inc.

  See details and how to joinNCT06312644